MedPath
HSA Approval

BEPROGENT CREAM

SIN09020P

BEPROGENT CREAM

BEPROGENT CREAM

November 28, 1996

ZUELLIG PHARMA PTE. LTD.

ZUELLIG PHARMA PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantZUELLIG PHARMA PTE. LTD.
Licence HolderZUELLIG PHARMA PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

CREAM

TOPICAL

Medical Information

D07CC01

betamethasone and antibiotics

Manufacturer Information

ZUELLIG PHARMA PTE. LTD.

HOE PHARMACEUTICALS SDN BHD

Active Ingredients

GENTAMICIN SULPHATE EQV GENTAMICIN

0.1% w/w

Gentamicin

BETAMETHASONE DIPROPIONATE EQV BETAMETHASONE

0.05% w/w

Betamethasone

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

BEPROGENT CREAM - HSA Approval | MedPath